Skip to content

Diagnostic Access to Self-Care & Health Services in Low- and Middle-Income Countries (DASH) – Phase II Study

Diagnostic Access to Self-Care & Health Services in Low- and Middle-Income Countries (DASH) – Phase II Study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
PACTR
Registry ID
PACTR202504585159735
Enrollment
5520
Registered
2025-04-24
Start date
2025-05-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS Malaria Pregnancy and Childbirth

Interventions

Community Health Worker facilitated rapid testing
Home based rapid self testing

Sponsors

University of Washington
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Young Child Eligibility Criteria: • Age =6 months and <7 years old; or as defined by local regulatory authorities • Resides in the household and has spent =1 night at the house in the prior four weeks • Plans to reside in the house for duration of the study • Parental written informed consent is provided for study procedures 2. Child and Adolescent Eligibility Criteria: • Age =7 years and <18 years old; or as defined by local regulatory authorities • Resides in the household and has spent =1 night at the house in the prior four weeks • Plans to reside in the house for duration of the study • Parental written informed consent is provided for study procedures, as necessary • Willing and able to provide age-appropriate assent for study procedures 3. Adult Eligibility Criteria: • Age =18 years old or 16-17 years old with a waiver of parental consent Parental consent waiver will be sought for individuals who have a child/children or are heads of a household due to the absence of an older person by death or marriage. • Resides in the household and has spent =1 night at the house in the prior four weeks • Plans to reside in the house for duration of the study • Willing and able to provide written informed consent for study procedures

Exclusion criteria

Exclusion criteria: not able to provide informed consent. Not planning to stay at the study region for the study duration

Design outcomes

Primary

MeasureTime frame
Primary Outcomes for Priority Conditions – Testing adoption: •Malaria: Participant self-report of testing for malaria (measured as ever tested between baseline and exit). •HIV: Participant self-report of testing for HIV (measured as ever tested after baseline). •Composite: Participant self-report of testing for malaria or HIV (measured as ever tested after baseline).

Secondary

MeasureTime frame
Secondary testing adoption outcomes for Priority Conditions • Malaria: Self-report of malaria test for each testing indication event after baseline (presence of a fever after the baseline enrollment visit) • HIV: Self-report of HIV test for each testing indication event after baseline (possible HIV exposure as defined by screening indication) • Composite: Proportion of testing indication events after baseline that received appropriate screening/testing for malaria and HIV.

Countries

Kenya

Contacts

Public ContactNorton Sang

Investigator

nsang@kemri-rctp.org+254715778930

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026